Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02728258
Title Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors NRG Oncology
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST